Slicast
Friday, September 11, 2026
DarkSubscribe
Slicast
AI Infrastructure · News & Analysis
Home › Chips & Hardware › Report
Chips & Hardware · Report

Bristol Myers Squibb deploys Nvidia's Vera Rubin AI supercomputer for pharmaceutical discovery, expanding enterprise GPU allocation.

Enterprise pharma validation of high-end Nvidia compute; demonstrates AI-driven productivity gains justify datacenter-scale AI infrastructure.
Trade pressSlicast · July 21, 2026 · US · Source: qz.com
importance 60
Read the original
Companies in this story
NvidiaCapex history →
In-depth analysis
CommentaryBroadcom vs Nvidia: Custom XPU Versus Merchant GPU in the Inference Build-OutCommentaryNvidia's Hugging Face Acquisition, September 2026: Developer Ecosystem at $12.93 Billion
Related reports
Chips & HardwareIntel reports earnings as Wall Street questions durability of AI chip rally amid competition from Nvidia and custom platforms.2026-07-21Chips & HardwareNvidia stock trades near record highs as AI demand drives surging earnings, buoyed by hyperscaler GPU allocation announcements.2026-07-21Chips & HardwareHuawei unveils AI supercomputer built with zero US components, demonstrating end-to-end Chinese chip ecosystem maturity.2026-07-21Chips & HardwareMicrosoft expands Azure AI infrastructure with AMD's Helios platform, set to launch at scale in H2 2026 as alternative to Nvidia GPUs.2026-07-21Chips & HardwareAMD launches Helios AI platform at scale for Microsoft Azure, offering compelling alternative to Nvidia GPU clusters for hyperscaler workloads.2026-07-21